Ostospray
Marketer
Sun Pharmaceutical Industries Ltd
Salt Composition
Calcitonin (Salmon) (200IU)
Overview Ostospray
Nasal OsteoPro is a medication indicated for osteoporosis management in postmenopausal women, enhancing bone density and reducing fracture risk. It may also alleviate bone pain related to Paget's disease. Administer as directed by your physician. Prior to application, gently clear your nasal passages. Occlude one nostril, administering the medication into the other via a forceful sniff to ensure deep penetration. Repeat for the opposite nostril. Concurrent calcium and vitamin D supplementation is recommended to optimize therapeutic efficacy. Commonly reported side effects include nasal discharge, epistaxis, backache, arthralgia, cephalalgia, and other nasal symptoms such as pruritus, irritation, and discomfort. While generally mild, persistent or bothersome symptoms warrant medical consultation for potential mitigation strategies. Prior to commencing treatment, inform your physician of any pre-existing cardiac, renal, or hepatic conditions. Pregnant or lactating individuals should seek medical advice before use.
Uses of Ostospray
Osteoporosis and Paget's disease in postmenopausal women
Major Benefits of Ostospray:
Follow your doctor's instructions, or consult the product label for usage guidelines.
Common Side effects of Ostospray:
- Runny nose
- Nosebleeds
- Nasal irritation
- Back pain
- Joint pain
- Headache
How to use Ostospray:
Follow your doctor's instructions or consult the product label for usage guidance.
How Ostospray works:
Calcitonin receptor activation is the mechanism of action for Ostospray. This medication inhibits osteoclast activity, reducing bone breakdown and consequently bolstering bone strength and fracture risk reduction.
SAFETY ADVICE
AlcoholNone
No known drug interactions.
PregnancyCONSULT YOUR DOCTOR
Using Ostospray during pregnancy may pose risks. While human research is scarce, animal studies indicate potential harm to a developing fetus. A physician will assess the advantages against possible dangers prior to any prescription. Seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
The use of Ostospray while breastfeeding is likely inadvisable. Available human data indicates potential transfer of the medication into breast milk, posing a possible risk to the infant.
DrivingNone
No known drug interactions.
KidneyNone
No known drug interactions.
LiverNone
No known drug interactions.
What if you forget to take Ostospray :
Should you forget a dose of Ostospray, take it immediately if you remember. If, however, your next dose is imminent, omit the missed dose and resume your usual dosing pattern. Never take a double dose.
Facts to Know About Ostospray
| Label | Value |
|---|---|
| Chemical Category | Endocrine Signals |
| Developing Habits | No. |
| Treatment Category | Pain Relievers |

